Ressource Scientifique
Poster
Poster
30/04/2025
TEQ103, a novel therapeutic for the treatment of breast cancer
These results demonstrate the significant durable antitumor effect of TEQ103 driven by the total dose administered. Read the poster!
Poster
30/04/2025
MTL-004, a promising new therapeutic for post-resection treatment of glioblastoma
MTL-004 was found to be safe and well-tolerated at a dose of 1 mg/kg, and was excreted mainly through urine. Read the poster!
Poster
29/04/2025
Metastasis Development Induced by Intracarotid Injection
We show a new TNBC mouse model of brain metastasis, induced by intracarotid injection, while assessing BBB integrity. Read the poster!
Poster
28/04/2025
Novel PSMA+ and FAP+ mouse models
We designed new mouse models, which could aid in the development of novel imaging or radiotherapy agents for two biomarkers. Read the poster!
Poster
28/04/2025
Pharmacological evaluation using the AbYlink TM regio-selective conjugation technology
AbYlink is a regio-selective labeling method, enabling a one-step conjugation of payloads to the Fc domain of an antibody. Read the poster!
Poster
28/04/2025
PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis
Our study highlights the versatility and translational relevance of PDXOs in cancer research. Read the poster!
Poster
07/04/2024
Exemples de modèles précliniques translationnels pour imiter la résistance aux médicaments contre le cancer
Resistance mechanisms are now well studied in vitro, based on mutated cell lines for specific resistance pathways. Discover our poster!
Poster
07/04/2024
Évaluation de l’efficacité des inhibiteurs de points de contrôle dans un modèle murin de système immunitaire humanisé dépourvu de récepteurs Fc gamma murins
Humanized immune system (HIS) mice are critical immuno-oncology tools for evaluating antibody-based therapeutic target engagement and efficacy in a human-like context
Poster
07/04/2024
Administration intracrânienne de MTL-004, un traitement post-résection prometteur pour le glioblastome
Gliomas (GBM), are exceptionally hard to treat, aggressive and genetically heterogeneous tumors. Read the poster to discover the case study!
Poster
07/04/2024
Nouvelles technologies et capacités soutenant le développement de nouveaux agents de radiothérapie moléculaire
Read our Oncodesign-Services' poster which provides cutting-edge technologies and products to support the development of radiopharmaceuticals for theranostics.
Poster
05/02/2024
Advancing Drug Discovery through 3D Cell Models: Unveiling Novel Hits and Mechanisms
Discover our findings highlight the importance of 3D cell models in drug discovery. Download the poster!
Poster
09/05/2023
Generative AI Empowers the Search for PIM-1 Kinase Inhibitors: unveiling Novel Promising Chemical Entities
Discover this new poster co-written by Oncodesign Services and Iktos on the Generative AI Empowers the Search for PIM-1 Kinase Inhibitors.